Browse studies
Find your next paid study
2 recruiting studies matching your filters
Prospective Observational Study of Outcomes After Gemcitabine, Docetaxel, Melphalan, and Carboplatin With Autologous Stem Cell Transplantation in Pediatric Relapsed/Refractory Germ Cell Tumors
To collect information about treatment outcomes in pediatric and adolescent patients with relapsed/refractory germ cells tumors who receive GemDMC with an ASCT.
Prospective Observational StudyGemcitabineDocetaxel+5 more
Estimated
~$10 – $750
M.D. Anderson Cancer CenterNCT07662018
Phase 1
A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias
To find the highest safe dose of ziftomenib that can be combined with venetoclax and azacitidine in pediatric participants with acute leukemia that has certain…
Refractory Acute LeukemiaPediatric Relapsed
Estimated
~$10 – $6,250
M.D. Anderson Cancer CenterNCT06397027